We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-3.55%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$16B
AUM Growth
-$1.4B
Cap. Flow
-$442M
Cap. Flow %
-2.77%
Top 10 Hldgs %
29.19%
Holding
720
New
51
Increased
199
Reduced
358
Closed
49

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$121M
2
ONC
BeOne Medicines Ltd
ONC
+$66.8M
3
ISRG icon
Intuitive Surgical
ISRG
+$56.6M
4
WELL icon
Welltower
WELL
+$48.8M
5
CRDO icon
Credo Technology Group
CRDO
+$45.3M

Top Sells

Rank Stock Value
1
ALTR
Altair Engineering Inc
ALTR
+$67M
2
UNH icon
UnitedHealth
UNH
+$44.7M
3
APH icon
Amphenol
APH
+$43.9M
4
BDX icon
Becton Dickinson
BDX
+$36.4M
5
LLY icon
Eli Lilly
LLY
+$36.1M

Sector Composition

Rank Sector Weight
1 Technology 31.51%
2 Healthcare 25.4%
3 Financials 11.6%
4 Consumer Discretionary 7.99%
5 Industrials 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TGT icon
351
Target
TGT
$65.6B
$4.37M 0.03%
41,868
-2,759
-6% -$345K
GPK icon
352
Graphic Packaging
GPK
$3.24B
$4.36M 0.03%
167,836
– –
CMG icon
353
Chipotle Mexican Grill
CMG
$48.8B
$4.33M 0.03%
86,295
-10,425
-11% -$567K
INTR icon
354
Inter&Co
INTR
$2.49B
$4.33M 0.03%
+636,000
New +$3.3M
PHM icon
355
Pultegroup
PHM
$24.5B
$4.32M 0.03%
42,000
+39,445
+1,544% +$4.26M
PCVX icon
356
Vaxcyte
PCVX
$8.08B
$4.28M 0.03%
113,390
-720
-0.6% -$57.6K
SWTX
357
DELISTED
SpringWorks Therapeutics
SWTX
$4.27M 0.03%
96,778
-67,237
-41% -$3.1M
CBOE icon
358
Cboe Global Markets
CBOE
$31B
$4.27M 0.03%
18,857
-6,143
-25% -$1.27M
BKR icon
359
Baker Hughes
BKR
$59.5B
$4.18M 0.03%
95,025
+1,529
+2% +$68.2K
PRU icon
360
Prudential Financial
PRU
$42.6B
$4.15M 0.03%
37,172
-11,390
-23% -$1.3M
DOCU
361
DocuSign
DOCU
$10.4B
$4.15M 0.03%
+50,936
New +$4.46M
FIS icon
362
Fidelity National Information Services
FIS
$23.8B
$4.11M 0.03%
54,987
-12,365
-18% -$930K
EW icon
363
Edwards Lifesciences
EW
$50B
$4.11M 0.03%
56,647
-69,029
-55% -$4.94M
LAUR icon
364
Laureate Education
LAUR
$5.29B
$4.07M 0.03%
+198,989
New +$3.84M
CNC icon
365
Centene
CNC
$30.1B
$4.04M 0.03%
66,596
-516,691
-89% -$31.2M
SQM icon
366
Sociedad Química y Minera de Chile
SQM
$19.5B
$4.03M 0.03%
+101,482
New +$4.07M
XYZ
367
Block Inc
XYZ
$49.2B
$4.03M 0.03%
74,200
+36,951
+99% +$2.76M
IMCR icon
368
Immunocore
IMCR
$1.72B
$4M 0.03%
134,785
– –
MSTR icon
369
Strategy Inc
MSTR
$35.7B
$3.97M 0.02%
13,776
+1,711
+14% +$543K
SYRE icon
370
Spyre Therapeutics
SYRE
$8.81B
$3.97M 0.02%
246,030
-1,561
-0.6% -$32.5K
INDA icon
371
iShares MSCI India ETF
INDA
$6.88B
$3.96M 0.02%
77,000
-29,000
-27% -$1.46M
SLG icon
372
SL Green Realty
SLG
$3.81B
$3.95M 0.02%
68,391
-36,523
-35% -$2.3M
CCI icon
373
Crown Castle
CCI
$33.4B
$3.92M 0.02%
37,574
-7,407
-16% -$692K
SBAC icon
374
SBA Communications
SBAC
$19.3B
$3.87M 0.02%
17,583
+5,205
+42% +$1.09M
F icon
375
Ford
F
$59.3B
$3.86M 0.02%
385,000
+32,712
+9% +$320K
13 14
15
16 17

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Candriam SCA's Q1 2025 Portfolio in Review

As of Q1 2025, Candriam SCA held 720 positions worth $16B, down 8.1% from $17.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Candriam SCA's Q1 2025 filing shows 51 new, 199 increased, 358 reduced and 49 closed positions. Its largest new stake was BeOne Medicines Ltd: 285,893 shares worth $77.8M. The largest sale was Altair Engineering Inc, an estimated $67M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q1 2025 buy was BeOne Medicines Ltd: 285,893 shares worth $77.8M.
  • Candriam SCA added most to Meta Platforms (Facebook) in Q1 2025, an estimated $121M increase.
  • Candriam SCA's biggest Q1 2025 reduction was UnitedHealth, cutting an estimated $44.7M.
  • Candriam SCA fully exited Altair Engineering Inc in Q1 2025, selling an estimated $67M.
  • Candriam SCA's ten largest holdings make up 29% of its $16B portfolio in Q1 2025.
  • Candriam SCA opened 51 new positions and closed 49 in Q1 2025.
  • Candriam SCA's portfolio value fell 8.1% quarter-over-quarter to $16B.

Based on Candriam SCA's 13F filing for Q1 2025, filed 14 May 2025.